Marco Troisi

404 citations
7 papers · 60 indexed · h-index 5
Topics
SARS-CoV-2 and COVID-19 Research (3 papers)COVID-19 epidemiological studies (2 papers)COVID-19 Clinical Research Studies (2 papers)
Partner nations
ItalyIndiaAlbania

In The Last Decade

Marco Troisi

6 papers receiving 60 citations

Peers

Marco Troisi
Comparison fields: 5 of 41
  • Molecular Biology 24
  • Infectious Diseases 24
  • Radiology, Nuclear Medicine and Imaging 12
  • Ecology 9
  • Oncology 9
Replace Raquel Ortiz with:
Raquel Ortiz Spain
Louise Downs United Kingdom
Graham T. Wehmeyer United States
David Devolder Belgium
Bremy Alburquerque United States
Lien Trinh United States
Dmitry N. Shcherbinin Russia
Claudia González-Rico Spain
Harish Rao India
Marco Troisi relative to Raquel Ortiz Spain Raquel Ortiz's profile →
Citations per field
00.5×4.5×
Raquel Ortiz · 1×
Citations per year

Countries citing papers authored by Marco Troisi

Since Specialization
Citations

This map shows the geographic impact of Marco Troisi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Troisi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Troisi more than expected).

Fields of papers citing papers by Marco Troisi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Troisi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Troisi. The network helps show where Marco Troisi may publish in the future.

Co-authorship network of co-authors of Marco Troisi

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Troisi. A scholar is included among the top collaborators of Marco Troisi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Troisi. Marco Troisi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 8
2 2
3 13
4 7
5 10
6 0
7 20

About Marco Troisi

Marco Troisi is a scholar working on Applied Microbiology and Biotechnology, Modeling and Simulation and Molecular Medicine, having authored 7 papers that have together received 60 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 epidemiological studies (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (4 citations), Infectious Diseases (24 citations) and Microbiology (8 citations). Marco Troisi has collaborated with scholars based in Italy, India and Albania. Frequent co-authors include Emanuele Andreano, Rino Rappuoli, Claudia Sala, Lucantonio Debellis, Anna Kabanova, Antonella Daniele, Lorenzo Polimeno, Adriana Mosca, Maria Teresa Viggiani and Luigì Santacroce. Their work appears in journals such as Cell Death and Differentiation, Frontiers in Microbiology and Current Opinion in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026